CVE-2023-34344

CVE-2023-34344 is a medium-severity vulnerability in Ami Megarac Sp-x with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-203.

Key facts

Description

AMI BMC contains a vulnerability in the IPMI handler, where an unauthorized attacker can use certain oracles to guess a valid username, which may lead to information disclosure.

Frequently asked questions

What is CVE-2023-34344?
AMI BMC contains a vulnerability in the IPMI handler, where an unauthorized attacker can use certain oracles to guess a valid username, which may lead to information disclosure.
How severe is CVE-2023-34344?
CVE-2023-34344 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2023-34344 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-34344?
CVE-2023-34344 affects Ami Megarac Sp-x. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-34344?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-34344 published?
CVE-2023-34344 was published on 2023-06-12 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ami Megarac Sp-x

All CVEs affecting Ami Megarac Sp-x →

Other CWE-203 (Observable Discrepancy) vulnerabilities

Browse all CWE-203 (Observable Discrepancy) vulnerabilities →